The Vermont Breast Cancer Surveillance System conducts research to improve breast cancer screening in the United States. Three areas of current focus include Risk-Based Screening, Evaluation of New Screening Technologies, and Prognostic Factors for DCIS.
We are members of two national consortium efforts to evaluate and improve cancer screening. We have been members of the Breast Cancer Surveillance Consortium since its initiation in 1994. In 2015 we became one of the founding members of the Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions. Through both consortia we engage in active research covering a wide variety of topics in breast cancer screening, diagnosis, treatment, and survivorship.